John L. Lubniewski

This profile gathers the share dealings of John L. Lubniewski in HTG Molecular Diagnostics, Inc, where the filings describe the role as chief executive. We count 47 filings; the first trade dates from 11 May 2015 and the latest from 9 December 2022.

Market trades split into 2 purchases (€35k) and 6 sales (€27k). Taken together, the purchases exceed the sales by €8,002. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 30 share grants.

Most recently, on 13 December 2022, the filings show a share grant worth €402 in HTG Molecular Diagnostics, Inc. The most recent open-market purchase was published on 12 August 2015, 4,106 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.